# FDA Inspection 680996 - Biomat USA, Inc. - September 10, 2010

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5b4c90b0-f2da-4d53-9a44-e5e1ebd0e137
Source feed: FDA_Inspections

> FDA Inspection 680996 for Biomat USA, Inc. on September 10, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 680996
- Company Name: Biomat USA, Inc.
- Inspection Date: 2010-09-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1209304 - 2023-06-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/434514d3-4426-474b-b6f4-8c1b268218aa)
- [FDA Inspection 1209304 - 2023-06-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8f11af5a-728a-43bd-9f80-547fd409270c)
- [FDA Inspection 1024597 - 2017-07-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/997e2c70-0471-4f57-b8f4-aef72cb456a0)
- [FDA Inspection 849943 - 2013-09-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/45697ca5-38a6-45fd-a175-4ee2c099b80c)

Company: https://www.keypedia.com/companies/biomat-usa-inc/7c4a83d5-bc60-4351-ab37-94428e858011

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d